Global Prebiotics for Dietary Supplements Market, by Ingredient Type (Galacto-oligosaccharides (GOS), Fructo-oligosaccharides (FOS), Xylooligosaccharides (XOS), Isomaltooligosaccharides (IMO) and Human milk oligosaccharides (HMO)), by Source (Plant (Including Botanicals) and Animal), by Distribution Channel (B2B (Generic) (Broker and Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,205.9 million in 2022, and is expected to exhibit a CAGR of 10.2% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
According to an article published by the Sustainability Science Journal in July 2018, the Middle East and North Africa (MENA) region was facing challenges such as persistent food and nutrition insecurity, increase in incidence of diet-related non-communicable diseases (NCDs), and others. This is expected to be a lucrative growth opportunity for prebiotics for dietary supplements market, as food and nutrition insecurity results in an increased demand for highly nutritious products such as prebiotics and probiotics.
Moreover, people's concern to maintain their gut health to prevent various health disorders is fuelling the prebiotics for dietary supplements market growth. The use of natural ingredients for a healthy and immunity-boosting diet provides growth opportunities for market.
Global Prebiotics for Dietary Supplements Market – Impact of Coronavirus (COVID-19) Pandemic
Lockdown or shutdown was imposed in several countries due to the COVID-19, which had a negative impact on the economy of the private healthcare sector. This lockdown resulted in the closure of industrial establishments, except manufacturing of essential commodities, and disruption in the supply chain of products.
Supply chain and manufacturing activities in North America, Asia Pacific, Europe, and other regions had been disrupted due to the lockdown. Furthermore, healthcare providers were facing challenges in terms of additional manpower, equipment, consumables, and other resources which are required to ensure safety in hospitals and provide treatment to patients with other diseases. This has also impacted the overall healthcare market negatively.
One of the biggest challenges due to the COVID-19 pandemic is supply in prebiotic ingredients to manufacture supplements and other drugs due to irregularities in the transportation system. For instance, Ernst & Young LLP (EY US), an audit firm, conducted a global survey of 200 senior-level supply chain executives in late 2020. The findings of the survey stated that the pandemic had substantial negative effects on trade, finance, health and education systems supply chains.